ATE375990T1 - Piperidin-indol derivate mit 5-ht6 affinität - Google Patents
Piperidin-indol derivate mit 5-ht6 affinitätInfo
- Publication number
- ATE375990T1 ATE375990T1 AT99915418T AT99915418T ATE375990T1 AT E375990 T1 ATE375990 T1 AT E375990T1 AT 99915418 T AT99915418 T AT 99915418T AT 99915418 T AT99915418 T AT 99915418T AT E375990 T1 ATE375990 T1 AT E375990T1
- Authority
- AT
- Austria
- Prior art keywords
- group
- 4alkyl
- 4alkoxy
- halo
- affinity
- Prior art date
Links
- XVTILWLVPDMCSO-UHFFFAOYSA-N 1h-indole;piperidine Chemical class C1CCNCC1.C1=CC=C2NC=CC2=C1 XVTILWLVPDMCSO-UHFFFAOYSA-N 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 7
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 5
- 125000001475 halogen functional group Chemical group 0.000 abstract 5
- -1 C3-7cycloalkyloxy Chemical group 0.000 abstract 3
- 108091005435 5-HT6 receptors Proteins 0.000 abstract 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 150000002475 indoles Chemical class 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 abstract 1
- 229920002554 vinyl polymer Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CA1999/000342 WO2000063203A1 (en) | 1999-04-21 | 1999-04-21 | Piperidine-indole compounds having 5-ht6 affinity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE375990T1 true ATE375990T1 (de) | 2007-11-15 |
Family
ID=4173364
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99915418T ATE375990T1 (de) | 1999-04-21 | 1999-04-21 | Piperidin-indol derivate mit 5-ht6 affinität |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1173432B9 (de) |
| JP (1) | JP4597386B2 (de) |
| AT (1) | ATE375990T1 (de) |
| AU (1) | AU778682B2 (de) |
| CA (1) | CA2370147C (de) |
| DE (1) | DE69937372T2 (de) |
| ES (1) | ES2291024T4 (de) |
| MX (1) | MXPA01010655A (de) |
| WO (1) | WO2000063203A1 (de) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1803720A1 (de) * | 2000-12-22 | 2007-07-04 | Wyeth a Corporation of the State of Delaware | Hetorocyclindazole und -Azaindazole Verbindungen als 5-Hydroxytryptamine-6 Liganden |
| BR0116323A (pt) * | 2000-12-22 | 2003-10-14 | Wyeth Corp | Compostos de heterociclilindazol e -azaindazol como ligandos de 5-hidroxitriptamina-6 |
| MXPA03006605A (es) | 2001-01-30 | 2003-09-22 | Lilly Co Eli | Esteres de indol-5-ilo del acido bencensulfonico como antagonistas del receptor 5-ht6. |
| PL367305A1 (en) * | 2001-06-07 | 2005-02-21 | F.Hoffmann-La Roche Ag | New indole derivatives with 5-ht6 receptor affinity |
| ITRM20010356A1 (it) * | 2001-06-21 | 2002-12-23 | Sigma Tau Ind Farmaceuti | "5-alogeno derivati della triptamina utili come ligandi del recettore5-ht6 e/o 5-ht7 della serotonina. |
| TW200301251A (en) | 2001-12-20 | 2003-07-01 | Wyeth Corp | Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
| AU2003238339A1 (en) * | 2002-02-01 | 2003-09-02 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor |
| SI1497266T1 (sl) | 2002-03-27 | 2008-10-31 | Glaxo Group Ltd | Derivati kinolina in njihova uporaba kot ligandi 5-ht6 |
| US7875605B2 (en) * | 2002-11-28 | 2011-01-25 | Suven Life Sciences Limited | N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them |
| CA2515571A1 (en) | 2003-02-14 | 2004-09-02 | Wyeth | Heterocyclyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands |
| WO2005005439A1 (en) * | 2003-07-09 | 2005-01-20 | Suven Life Sciences Limited | Benzothiazino indoles |
| EP1558582B1 (de) | 2003-07-22 | 2005-12-21 | Arena Pharmaceuticals, Inc. | Diaryl- und arylheteroarylharnstoffderivate als modulatoren des 5-ht2a-serotoninrezeptors, die sich zur prophylaxe und behandlung von damit im zusammenhang stehenden erkrankungen eignen |
| GB0321473D0 (en) | 2003-09-12 | 2003-10-15 | Glaxo Group Ltd | Novel compounds |
| WO2007098418A1 (en) * | 2006-02-17 | 2007-08-30 | Memory Pharmaceuticals Corporation | Compounds having 5-ht6 receptor affinity |
| MX2009006077A (es) | 2007-01-08 | 2009-06-17 | Suven Life Sciences Ltd | Compuestos de 5-(heterociclil)alquil-n-(arilsulfonil)indol y su uso como ligandos de la 5-hidroxitriptamina6. |
| EP2155724A1 (de) * | 2007-03-23 | 2010-02-24 | Abbott GmbH & Co. KG | Zur behandlung von erkrankungen, die auf eine modulation des serotonin-5-ht6-rezeptors ansprechen, geeignete azetidinverbindungen |
| KR101162482B1 (ko) | 2007-05-03 | 2012-07-03 | 수벤 라이프 사이언시스 리미티드 | 아미노알콕시 아릴술폰아미드 화합물 및 ５-ｈｔ６ 리간드로서의 그의 용도 |
| DK2200980T3 (da) | 2007-10-26 | 2011-11-21 | Suven Life Sciences Ltd | Aminoarylsulfonamidforbindelser og deres anvendelse som 5-HT6-ligander |
| EP2254564A1 (de) | 2007-12-12 | 2010-12-01 | Glaxo Group Limited | Kombinationen mit 3-phenylsulfonyl-8-piperazinyl-1yl-chinolin |
| US20110021538A1 (en) | 2008-04-02 | 2011-01-27 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
| US8318725B2 (en) | 2008-09-17 | 2012-11-27 | Suven Life Sciences Limited | Aryl indolyl sulfonamide compounds and their use as 5-HT6 ligands |
| HRP20130721T1 (en) | 2008-09-17 | 2013-09-30 | Suven Life Sciences Limited | Aryl sulfonamide amine compounds and their use as 5-ht6 ligands |
| WO2010062321A1 (en) | 2008-10-28 | 2010-06-03 | Arena Pharmaceuticals, Inc. | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto |
| AU2010340745B2 (en) | 2010-01-05 | 2014-11-20 | Suven Life Sciences Limited | Sulfone compounds as 5-HT6 receptor ligands |
| WO2015090233A1 (en) | 2013-12-20 | 2015-06-25 | Sunshine Lake Pharma Co., Ltd. | Aromatic heterocyclic compounds and their application in pharmaceuticals |
| EP3166924B1 (de) | 2014-07-08 | 2019-02-20 | Sunshine Lake Pharma Co., Ltd. | Aromatische heterocyclische derivate und pharmazeutische anwendungen davon |
| HK1245660A1 (zh) | 2015-06-12 | 2018-08-31 | Axovant Sciences Gmbh | 有用於预防和治疗rem睡眠行为障碍的二芳基脲和芳基脲衍生物 |
| WO2017011767A2 (en) | 2015-07-15 | 2017-01-19 | Axovant Sciences Ltd. | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease |
| MX2023006652A (es) * | 2020-12-07 | 2023-09-21 | Mindset Pharma Inc | Derivados de amina-indol-3-ciclica como agentes serotonergicos para el tratamiento de trastornos del snc. |
| AU2022329895A1 (en) * | 2021-08-20 | 2024-03-28 | Mindset Pharma Inc. | N-substituted indole derivatives as serotonergic agents useful for the treatment of disorders related thereto |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE58370B1 (en) * | 1985-04-10 | 1993-09-08 | Lundbeck & Co As H | Indole derivatives |
| DK158590D0 (da) * | 1990-07-02 | 1990-07-02 | Lundbeck & Co As H | Indolderivater |
| TW263508B (de) * | 1991-02-12 | 1995-11-21 | Pfizer | |
| US5846982A (en) * | 1996-06-14 | 1998-12-08 | Eli Lilly And Company | Inhibition of serotonin reuptake |
-
1999
- 1999-04-21 ES ES99915418T patent/ES2291024T4/es not_active Expired - Lifetime
- 1999-04-21 AT AT99915418T patent/ATE375990T1/de not_active IP Right Cessation
- 1999-04-21 EP EP99915418A patent/EP1173432B9/de not_active Expired - Lifetime
- 1999-04-21 MX MXPA01010655A patent/MXPA01010655A/es active IP Right Grant
- 1999-04-21 WO PCT/CA1999/000342 patent/WO2000063203A1/en not_active Ceased
- 1999-04-21 DE DE69937372T patent/DE69937372T2/de not_active Expired - Lifetime
- 1999-04-21 CA CA002370147A patent/CA2370147C/en not_active Expired - Fee Related
- 1999-04-21 AU AU34035/99A patent/AU778682B2/en not_active Ceased
- 1999-04-21 JP JP2000612293A patent/JP4597386B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1173432B9 (de) | 2008-10-15 |
| JP4597386B2 (ja) | 2010-12-15 |
| DE69937372T2 (de) | 2008-06-26 |
| ES2291024T3 (es) | 2008-02-16 |
| AU3403599A (en) | 2000-11-02 |
| ES2291024T4 (es) | 2009-03-01 |
| JP2002542241A (ja) | 2002-12-10 |
| DE69937372D1 (de) | 2007-11-29 |
| EP1173432B1 (de) | 2007-10-17 |
| EP1173432A1 (de) | 2002-01-23 |
| CA2370147A1 (en) | 2000-10-26 |
| AU778682B2 (en) | 2004-12-16 |
| WO2000063203A1 (en) | 2000-10-26 |
| MXPA01010655A (es) | 2002-11-04 |
| CA2370147C (en) | 2009-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69937372D1 (de) | Piperidin-indol derivate mit 5-ht6 affinität | |
| CA2287551A1 (en) | 3-(2-pyrrolidinylmethyl)-indole compounds having 5-ht6 affinity | |
| GB9801690D0 (en) | Therapeutic agents | |
| DK0841929T3 (da) | Quinoloner og deres terapeutiske anvendelse | |
| WO2002046129A3 (en) | Inhibitors of histone deacetylase | |
| DK1104760T3 (da) | Sulfamoylheteroarylpyrazolforbindelser som anti-inflammatoriske/analgetiske midler | |
| TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
| DK0889877T3 (da) | Meta-substituerede phenylenderivater og deres anvendelse som alfav-beta3-integrin-antagonister eller -inhibitorer | |
| CA2335285A1 (en) | Bicyclic piperidine and piperazine compounds having 5-ht6 receptor affinity | |
| IL114315A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same for inhibiting phosphodiesterase IV | |
| DK0889876T3 (da) | Meta-substituerede phenylensulfonamidderivater | |
| BG101422A (bg) | Бензоксазолни производни като бронхоразширяващи средства | |
| NO963731L (no) | Behandling av obsessive-kompulsive sykdommer med 5HT2-antagonister | |
| WO2000008048A3 (en) | Inhibitor of histone deacetylase | |
| EA200300717A1 (ru) | Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов | |
| ATE252576T1 (de) | Heteroarylphenylpyrazolverbindungen zur verwendung als analgetisches/entzündungshemmendes mittel | |
| BR0108816A (pt) | Derivados de quinolina como antagonistas alfa-2 | |
| NO984740L (no) | Isatinderivater som acetylcholinesteraseinhibitorer og analgetiske midler | |
| WO2000005214A3 (en) | Isoquinolines as urokinase inhibitors | |
| PT1204658E (pt) | Agonistas benzofurilpiperazina de serotonina | |
| AU2001261707A1 (en) | Pirazino '1$m(1)2$m(1) :1, 6! pyrido '3,4-b! indole derivatives | |
| EP0816338A4 (de) | 3-(bis-substituierte-phenylmethylen)oxindol-derivate | |
| DE69512310D1 (de) | Glukopyranosid-Benzothiophene | |
| EA200401099A1 (ru) | Производные гетероциклического амида | |
| ATE243695T1 (de) | 5-bicycloindolverbindungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |